The market access environment in Canada has multiple stakeholders, and different strategies are required for public and private payers. The private payer community is varied and includes pharmacy benefit managers, health benefit consultants, and private insurers. In Canada, the private sector makes up greater than half of prescription drug purchases.

Over the years the world of prescription drugs has changed tremendously in Canada. We see more highly specialized therapeutics, for patients with increasing unmet need, and more treatments are being administered outside the hospital setting.

Private payers are a critical part of the market access landscape in Canada and are essential to the success of a new prescription drug launch. With different needs and criteria for reimbursement, a dedicated strategic plan is necessary in order to optimize reimbursement for this large market in Canada.

IMAC has extensive market access experience and a dedicated private payer specialist with decades of industry experience working with Canadian private payers. Our considerable experience informs our strategy for successful reimbursement submissions tailored to the specific requirements and needs of this diverse but important group.